TR200102929T2 - Farmasötik bileşikler. - Google Patents
Farmasötik bileşikler.Info
- Publication number
- TR200102929T2 TR200102929T2 TR2001/02929T TR200102929T TR200102929T2 TR 200102929 T2 TR200102929 T2 TR 200102929T2 TR 2001/02929 T TR2001/02929 T TR 2001/02929T TR 200102929 T TR200102929 T TR 200102929T TR 200102929 T2 TR200102929 T2 TR 200102929T2
- Authority
- TR
- Turkey
- Prior art keywords
- compounds
- pharmaceutical compounds
- relates
- inflammatory
- activity
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 2
- 150000003431 steroids Chemical class 0.000 abstract 2
- 230000009885 systemic effect Effects 0.000 abstract 2
- 206010048554 Endothelial dysfunction Diseases 0.000 abstract 1
- 230000000964 angiostatic effect Effects 0.000 abstract 1
- 230000008694 endothelial dysfunction Effects 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 230000036542 oxidative stress Effects 0.000 abstract 1
- 230000003637 steroidlike Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Toxicology (AREA)
- Pain & Pain Management (AREA)
- Biochemistry (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT1999MI000751A IT1311922B1 (it) | 1999-04-13 | 1999-04-13 | Composti farmaceutici. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200102929T2 true TR200102929T2 (tr) | 2002-04-22 |
Family
ID=11382683
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2001/02929T TR200102929T2 (tr) | 1999-04-13 | 2000-04-11 | Farmasötik bileşikler. |
| TR2002/01899T TR200201899T2 (tr) | 1999-04-13 | 2000-04-11 | Farmasötik bileşikler |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2002/01899T TR200201899T2 (tr) | 1999-04-13 | 2000-04-11 | Farmasötik bileşikler |
Country Status (25)
| Country | Link |
|---|---|
| US (3) | US6909007B1 (https=) |
| EP (2) | EP1169337B1 (https=) |
| JP (1) | JP2002542162A (https=) |
| KR (2) | KR100687821B1 (https=) |
| CN (2) | CN1296380C (https=) |
| AT (1) | ATE274521T1 (https=) |
| AU (2) | AU766798B2 (https=) |
| BR (1) | BR0009696A (https=) |
| CA (2) | CA2586538C (https=) |
| DE (1) | DE60013266T2 (https=) |
| DK (1) | DK1169337T3 (https=) |
| ES (1) | ES2226805T3 (https=) |
| HU (1) | HUP0201872A3 (https=) |
| IL (2) | IL145633A0 (https=) |
| IT (1) | IT1311922B1 (https=) |
| MX (1) | MXPA01010212A (https=) |
| NO (2) | NO323374B1 (https=) |
| NZ (1) | NZ514572A (https=) |
| PL (1) | PL199579B1 (https=) |
| PT (1) | PT1169337E (https=) |
| RU (1) | RU2240325C2 (https=) |
| SI (1) | SI1169337T1 (https=) |
| TR (2) | TR200102929T2 (https=) |
| WO (1) | WO2000061604A2 (https=) |
| ZA (1) | ZA200108124B (https=) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AP2002002582A0 (en) | 1999-12-23 | 2002-09-30 | Nitromed Inc | Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| DE60122939T2 (de) | 2000-12-21 | 2007-01-11 | Nitromed, Inc., Bedford | Substituierte arylverbindungen als neue, cyclooxygenase-2-selektive inhibitoren, zusammensetzungen und verwendungsverfahren |
| IT1320176B1 (it) * | 2000-12-22 | 2003-11-26 | Nicox Sa | Dispersioni solide di principi attivi nitrati. |
| EP1219306A1 (en) * | 2000-12-29 | 2002-07-03 | Nicox S.A. | Compositions comprising cyclodextrins and NO- releasing drugs |
| US6696592B2 (en) | 2001-05-22 | 2004-02-24 | Nicox-S.A. | Methods of making 21-[4′-(nitrooxyalkyl)benzoate] corticosteroid derivatives and intermediates useful in the synthesis thereof |
| ITMI20011307A1 (it) * | 2001-06-21 | 2002-12-21 | Nicox Sa | Farmaci per l'epilessia |
| ITMI20020148A1 (it) | 2002-01-29 | 2003-07-29 | Nicox Sa | Nuovi corticosteroidi |
| ITMI20021025A1 (it) * | 2002-05-14 | 2003-11-14 | Nicox Sa | Farmaci per il trattamento acuto di disfunzioni del circolo venoso epatico e portale |
| CA2487414A1 (en) | 2002-06-11 | 2003-12-18 | Nitromed, Inc. | Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| JP2005535642A (ja) | 2002-06-28 | 2005-11-24 | ニトロメッド インコーポレーティッド | オキシムおよび／またはヒドラゾンを含有するニトロソ化および／またはニトロシル化シクロオキシゲナーゼ−２選択的阻害剤、組成物、および使用方法 |
| AU2003247792B2 (en) | 2002-07-03 | 2009-09-24 | Nicox S.A. | Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| US7244753B2 (en) | 2002-07-29 | 2007-07-17 | Nitromed, Inc. | Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| CN100513415C (zh) * | 2005-08-03 | 2009-07-15 | 中国人民解放军军事医学科学院毒物药物研究所 | 胆汁酸衍生物及其医药用途 |
| CN102134269A (zh) | 2005-09-02 | 2011-07-27 | 尼科克斯公司 | 糖皮质激素硝酰氧基衍生物 |
| US8802726B2 (en) | 2006-02-03 | 2014-08-12 | Nicox S.A. | Use of nitrooxyderivative of drug for the treatment of muscular dystrophies |
| US7645749B2 (en) | 2006-04-03 | 2010-01-12 | Forbes Medi-Tech Inc. | Sterol/stanol nitroderivatives and use thereof |
| US7645748B2 (en) * | 2006-04-03 | 2010-01-12 | Forbes Medi-Tech Inc. | Sterol/stanol phosphorylnitroderivatives and use thereof |
| EP2109617A1 (en) * | 2007-02-05 | 2009-10-21 | Nicox S.A. | Nitric oxide releasing steroids |
| US20090087425A1 (en) * | 2007-08-10 | 2009-04-02 | Topigen Pharmaceuticals Inc. | Combination of nitroderivatized steroid and bronchodilator for treating respiratory disease |
| US20090088411A1 (en) * | 2007-08-31 | 2009-04-02 | Topigen Pharmaceuticals Inc. | No-donating corticosteroid with improved pharmacokinetic, anti-inflammatory and vasodilatory properties |
| CA2703723A1 (en) * | 2007-10-19 | 2009-04-23 | Burnham Institute Of Medical Research | Inhibitors of anti-apoptotic proteins |
| JP2011529933A (ja) | 2008-08-05 | 2011-12-15 | ニコックス エス エイ | 網膜および黄斑の疾患の治療のための新規なｎｏ放出性ステロイド |
| EP2560634A1 (en) | 2010-04-23 | 2013-02-27 | Piramal Enterprises Limited | Nitric oxide releasing prodrugs of therapeutic agents |
| CU20110244A7 (es) | 2011-12-27 | 2013-08-29 | Ct De Investigación Y Desarrollo De Medicamentos Cidem | Sistemas espiroesteroidales con efectos neuroactivos y anti-inflamatorios |
| CA2897571C (en) | 2013-01-21 | 2018-12-18 | Apparao Satyam | Nitric oxide releasing prodrugs of therapeutic agents containing at least one carboxylic acid group |
| KR101711513B1 (ko) * | 2015-06-26 | 2017-03-02 | 주식회사 엘지생활건강 | 피부 개선용 조성물 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2077750B1 (https=) * | 1970-02-11 | 1973-03-16 | Clin Byla Ets | |
| GB1458372A (en) | 1973-03-05 | 1976-12-15 | Leo Ab | Steroid carbamates and allophanates |
| JPS5845724A (ja) * | 1981-09-11 | 1983-03-17 | Oriza Yuka Kk | オリザノ−ル乳化液の製造法 |
| FR2600653B1 (fr) | 1986-06-24 | 1988-12-16 | Pasteur Strasbourg Universite | Composes de synthese associative d'acides amines soufres ou non soufres avec des derives du d-4 pregnene 3,20-dione ou avec des derives du d-1,4 pregnadiene 3,20-dione aux proprietes glucocorticoides et anti-inflammatoires, procedes d'obtention, compositions pharmaceutiques les contenant. proprietes pharmacologiques et applications |
| IT1204571B (it) * | 1987-05-08 | 1989-03-10 | Chiesi Farma Spa | Esteri di 1,4:3,6-dianidrosorbitolo-2-mononitrato e 5-mononitrato,loro procedimento di preparazione e loro composizioni farmaceutiche |
| WO1989000202A2 (en) * | 1987-06-29 | 1989-01-12 | Massachusetts Institute Of Technology | Method for producing novel polyester biopolymers |
| DE4000397A1 (de) * | 1990-01-09 | 1991-07-11 | Hoechst Ag | Lipidselektive antioxidantien sowie deren herstellung und verwendung |
| JPH04273892A (ja) * | 1991-02-27 | 1992-09-30 | Kao Corp | 新規な２１−置換ステロイド化合物 |
| JP3108474B2 (ja) | 1991-08-07 | 2000-11-13 | 日清製粉株式会社 | 活性型ビタミンｄ誘導体 |
| ATE144250T1 (de) | 1991-12-26 | 1996-11-15 | Wisconsin Alumni Res Found | 26,27-dimethylen-1-alpha, 25-dihydroxyvitamin-d2 und 26,27-dihydroxyvitamin-d2 und verfahren zu ihrer herstellung |
| EP0562497A1 (en) | 1992-03-27 | 1993-09-29 | Nisshin Flour Milling Co., Ltd. | 1 alpha-hydroxy vitamins D7 and D4' processes for the preparation thereof and pharmaceutical compositions |
| US5194431A (en) | 1992-07-08 | 1993-03-16 | Wisconsin Alumni Research Foundation | 24-cyclopropane vitamin D derivatives |
| US5707984A (en) * | 1995-12-08 | 1998-01-13 | G. D. Searle & Co. | Steroid nitrite/nitrate ester derivatives useful as anti-inflammatory drugs |
| US5837698A (en) | 1996-05-02 | 1998-11-17 | G. D. Searle & Co. | Steroid nitrite and nitrate ester derivatives useful as anti-inflammatory drugs |
| US5985862A (en) * | 1996-05-02 | 1999-11-16 | G.D. Searle & Co. | Pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs |
| DE19634793A1 (de) * | 1996-08-29 | 1998-03-05 | Sanol Arznei Schwarz Gmbh | S- und O-Nitratoacylverbindungen |
| IT1285770B1 (it) * | 1996-10-04 | 1998-06-18 | Nicox Sa | Composti corticoidei |
-
1999
- 1999-04-13 IT IT1999MI000751A patent/IT1311922B1/it active
-
2000
- 2000-04-11 CA CA2586538A patent/CA2586538C/en not_active Expired - Fee Related
- 2000-04-11 DE DE60013266T patent/DE60013266T2/de not_active Expired - Lifetime
- 2000-04-11 AT AT00917075T patent/ATE274521T1/de not_active IP Right Cessation
- 2000-04-11 CN CNB008087741A patent/CN1296380C/zh not_active Expired - Fee Related
- 2000-04-11 WO PCT/EP2000/003238 patent/WO2000061604A2/en not_active Ceased
- 2000-04-11 TR TR2001/02929T patent/TR200102929T2/xx unknown
- 2000-04-11 CN CNA2006101516855A patent/CN1916013A/zh active Pending
- 2000-04-11 IL IL14563300A patent/IL145633A0/xx active IP Right Grant
- 2000-04-11 CA CA002370446A patent/CA2370446C/en not_active Expired - Fee Related
- 2000-04-11 PL PL350775A patent/PL199579B1/pl unknown
- 2000-04-11 US US09/926,327 patent/US6909007B1/en not_active Expired - Fee Related
- 2000-04-11 HU HU0201872A patent/HUP0201872A3/hu unknown
- 2000-04-11 EP EP00917075A patent/EP1169337B1/en not_active Expired - Lifetime
- 2000-04-11 KR KR1020017012940A patent/KR100687821B1/ko not_active Expired - Fee Related
- 2000-04-11 JP JP2000611546A patent/JP2002542162A/ja active Pending
- 2000-04-11 ES ES00917075T patent/ES2226805T3/es not_active Expired - Lifetime
- 2000-04-11 SI SI200030523T patent/SI1169337T1/xx unknown
- 2000-04-11 RU RU2001127575/04A patent/RU2240325C2/ru not_active IP Right Cessation
- 2000-04-11 PT PT00917075T patent/PT1169337E/pt unknown
- 2000-04-11 NZ NZ514572A patent/NZ514572A/xx unknown
- 2000-04-11 TR TR2002/01899T patent/TR200201899T2/xx unknown
- 2000-04-11 MX MXPA01010212A patent/MXPA01010212A/es active IP Right Grant
- 2000-04-11 EP EP04102751A patent/EP1475386A3/en not_active Withdrawn
- 2000-04-11 BR BR0009696-2A patent/BR0009696A/pt not_active IP Right Cessation
- 2000-04-11 AU AU38201/00A patent/AU766798B2/en not_active Ceased
- 2000-04-11 DK DK00917075T patent/DK1169337T3/da active
- 2000-04-11 KR KR1020067024049A patent/KR100744701B1/ko not_active Expired - Fee Related
-
2001
- 2001-10-03 ZA ZA200108124A patent/ZA200108124B/xx unknown
- 2001-10-10 NO NO20014925A patent/NO323374B1/no unknown
-
2004
- 2004-01-22 AU AU2004200263A patent/AU2004200263B2/en not_active Ceased
-
2005
- 2005-01-04 US US11/028,198 patent/US7186708B2/en not_active Expired - Fee Related
-
2006
- 2006-05-02 IL IL175398A patent/IL175398A0/en unknown
- 2006-12-13 NO NO20065784A patent/NO20065784L/no not_active Application Discontinuation
- 2006-12-22 US US11/643,887 patent/US7524836B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200102929T2 (tr) | Farmasötik bileşikler. | |
| TR200102928T2 (tr) | Farmasötik bileşikler. | |
| NO20091190L (no) | Fremgangsmater og sammensetninger for behandling av kreft | |
| TR200201082T2 (tr) | Glikopriranoziloksipirazol türevleri | |
| BG66075B1 (en) | Hormone replacement therapy using a combination of conjugated estrogens and medroxyprogesterone acetate | |
| PE34998A1 (es) | Un atomizador nasal que contiene un esteroide intranasal y un antihistaminico | |
| TR200002751T2 (tr) | Sistemik etkisi olan lokal hormon terkibi | |
| DE50312034D1 (de) | Liposomale glucocorticoide | |
| MA26843A1 (fr) | NOUVELLES COMPOSITIONS ESTRO-PROGESTATIVES TOPIQUES à EFFET SYSTÉMIQUE | |
| NO20016046L (no) | Administrering av ikke-orale androgene steroider til kvinner | |
| MX2007001357A (es) | Biomarcadores de plaquetas para cancer. | |
| CY1105065T1 (el) | Φαρμακευτικα μεσα βασιζομενα σε γεσταγονα για δepματικη χρηση | |
| DK1053239T3 (da) | Gluccocorticoid-selektive, anti-inflammatoriske midler | |
| CY1109451T1 (el) | 17βητα-ακυλ-17αλφα-προπυνυλ-11βητα-(κυκλικα αμινο)αρυλ στεροειδη και παραγωγα αυτων που εχουν ιδιοτητες ορμονικου ανταγωνιστη | |
| CO5680405A2 (es) | Formulacion de lamotrigina de liberacion prolongada y uso de la misma para su preparacion | |
| TR200102939T2 (tr) | Farmasötik bileşikler | |
| AR046580A1 (es) | Derivados de estrona 3,15-sustituidos que representan compuestos inhibidores de deshidrogenasa 17b-hidroxiesteroide de tipo i (17b-hsd1), preparaciones farmaceuticas que los contienen, y procedimientos para su preparacion | |
| BR0014355A (pt) | Derivados de sapogenina e seu uso no tratamento de disfunção cognitiva | |
| MX2022001066A (es) | Derivados de saponina con ventana terapeutica mejorada. | |
| DE50308933D1 (de) | Zusammensetzung, enthaltend ein androgenes 11-b-halogensteroid und ein gestagen sowie m nnliches kontrazeptivum auf basis dieser zusammensetzung | |
| DK0986573T3 (da) | Ikke estrogene derivater af estradiol med antioxidativ virkning | |
| EP3908296A4 (en) | USE OF AN ANTI-CD45 ANTIBODY-DRUG CONJUGATE (ADC) IN CELL THERAPY | |
| WO2001040255A3 (en) | 14,15-beta-methylene substituted androgens | |
| PE20011005A1 (es) | Combinaciones de un inhibidor de fosfodiesterasa 4 y un antiinflamatorio esteroideo para el tratamiento de las enfermedades pulmonares | |
| DE602006020605D1 (de) | Entzündungshemmende zusammensetzungen und anwendungsverfahren |